[The research of sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer patients].
Zhonghua Zhong Liu Za Zhi
; 41(8): 565-568, 2019 Aug 23.
Article
em Zh
| MEDLINE
| ID: mdl-31434445
ABSTRACT
With the extensive use of sentinel lymph node biopsy (SLNB), some breast cancer patients could avoid axillary lymph node dissection (ALND) and its complications. Neoadjuvant chemotherapy plays an important role in the multimodality therapies of breast cancer. After neoadjuvant chemotherapy, some patients with breast cancer were down-staged from positive axillary lymph node (cN+ ) to clinically negative (cN0). For these patients, the feasibility and safety of sentinel lymph node biopsy remains controversial. However, with the application of new technologies, SLNB is expected to become the main treatment for breast cancer patients with stage cN0 after neoadjuvant chemotherapy.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Mama
/
Pesquisa Biomédica
Limite:
Female
/
Humans
Idioma:
Zh
Revista:
Zhonghua Zhong Liu Za Zhi
Ano de publicação:
2019
Tipo de documento:
Article
País de afiliação:
China